Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Free Cash Flow (2024 - 2025)

Connect Biopharma Holdings' Free Cash Flow history spans 2 years, with the latest figure at -$17.4 million for Q3 2025.

  • For Q3 2025, Free Cash Flow fell 32.58% year-over-year to -$17.4 million; the TTM value through Sep 2025 reached -$40.7 million, down 87.24%, while the annual FY2024 figure was -$750000.0, 825.93% down from the prior year.
  • Free Cash Flow for Q3 2025 was -$17.4 million at Connect Biopharma Holdings, down from -$12.9 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$313000.0 in Q4 2024 and bottomed at -$17.4 million in Q3 2025.